GAMA Healthcare Bolsters Science and Innovation Team with Four New Hires

29 July 2020: Announced today, GAMA Healthcare, the number one supplier of Clinell disinfectant wipes to the NHS, has added four roles to its expanding Science and Innovation (S&I) team. In light of the COVID-19 pandemic, GAMA Healthcare looks to address the increase of demand for essential disinfectants not only in hospital settings but also for businesses, retail and the home.

Since joining GAMA Healthcare in September 2019 as S&I Director, Dr Teresa Layer has been responsible for innovation and new product pipeline for brands including Clinell. Hired as a values-based research and development leader with over 20 years of experience and previously Vice-President of Oral Health and Skin Health R&D at GSK Consumer Healthcare, Teresa brought strong experience in strategic planning for consumer health delivered through retail and used by all. As well as delivering scientifically differentiated pipeline innovation.

First hire of the S&I team, Dr Layer comments: “Through this period of accelerated growth, the Science and Innovation Team will be critical for GAMA Healthcare to drive our ongoing leadership and product pipeline in surface and skin disinfection as well as disinfection through novel equipment. As we build a technical team of world class scientific professionals, the strategic intent is to deliver a five year pipeline of exciting, patient/consumer-centric novel products, underpinned by scientific excellence.”

While advancing the innovative pipeline at GAMA Healthcare, Teresa has head-hunted specialist team members with skills and experience which are in line with the evolving business need over the last six months.

• Matt Duggan, Scientific Collaborations and Open Innovation Lead, joins from Reckitt-Benckiser (RB) with experience in numerous industries from healthcare to renewable energy. Reinforcing the focus of translating science where there is consumer and business need, GAMA Healthcare created this role to funnel innovation from all academia and external research partners to fuel the product pipeline.
• Csaba Gnadt, Product Optimisation and Technical Transfer Team Leader has over 20 years of experience in scaling up innovative new products and their efficient manufacture. Initially trained as a chemist, Csaba has optimised product development and manufacture for a range of personal care and household cleaning brands across Unilever’s portfolio.
• Giles Crowley, Development Formulation Scientist, brings extensive experience in science-based formulation chemistry. He is a specialist in hard surface cleaning from two decades experience at Unilever and his academic achievements include a Master’s Degree in Polymer Science.

Dr Guy Braverman, Managing Director and Co-Founder, GAMA Healthcare comments: “This is a critical time for many healthcare leaders. For us, it was especially important to bring on the right people who could offer expertise from potential growth sectors including consumer goods. These appointments will not only optimise the current product development and manufacture at our growing factory network, but we’re also really excited about the innovative thinking they can bring to our expanding pipeline.”

About GAMA Healthcare.

GAMA Healthcare is a dynamic, innovative company at the forefront of infection control technology. The company specialises in the manufacture and distribution of revolutionary infection prevention and control products and the provision of exceptional aftercare support.  It is committed to providing scientifically proven infection prevention and control products that have been rigorously tested. GAMA produces high-quality products which truly kill pathogens and harmful microorganisms. The Clinell Universal Wipes are the NHS’ number 1 most used disinfectant wipe, with 9 out of 10 NHS hospitals relying on them to help protect patients and healthcare workers from the risk of infection.